1.0 CEUs
Long-acting Antiretrovirals for Treatment and Prevention: Promises and Pitfalls
Module Description Designed for the HIV healthcare professional, this webinar will look at the emergence of long-acting HIV treatments and how they present both promising opportunities and potential challenges in the management of HIV. Our aim is to explore the best practices in incorporating these treatments into clinical practice, as well as to discuss potential pitfalls and strategies for mitigating them.
Credit Dates 3/20/2024 – 3/19/2025
Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine.
This activity is supported by an independent educational grant from ViiV.
Credit Dates 3/20/2024 – 3/19/2025
Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine.
This activity is supported by an independent educational grant from ViiV.
Learning Objectives
- Discuss the use of long-acting ART in people with HIV with virologic suppression.
- Evaluate emerging data on long-acting ART in people with HIV with adherence challenges.
- Compare and contrast long-acting options for pre-exposure prophylaxis (PrEP).
- Describe upcoming options for long-acting ART and PrEP in the future.
Target Audience This activity is intended for physicians, PAs, NPs, RNs, and pharmacists who are engaged in the care of people with HIV.
Estimated Time to Complete the Activity: 1 hour
Presenter: Monica Gandhi MD, MPH
Director | UCSF-Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief | Division of HIV, Infectious Diseases, and Global Medicine
Medical Director | “Ward 86” HIV Clinic, San Francisco General Hospital
Instructions for Credit There are no fees for participating and receiving CME/CE credit for this activity.
Participation in this self-study activity should be completed in approximately 1.0 hour. To successfully complete this activity and receive CE credit, learners must follow these steps during the period from March 20, 2024 through March 19, 2025:
- Review the objectives and disclosures
- Study the educational content
- Visit https://www.paceducation.com/LAAenduring
- Complete the activity evaluation
If you have questions regarding the certification of this activity, please contact PACE by emailing customersupport@paceducation.com.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education PACE designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number -JA4008073-9999-24-028-H02-P)
Type of Activity: Knowledge
Continuing Nursing Education The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour. Designated for 0.75 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
Disclosure of Conflict of Interest
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.
Dr. Monica Gandhi, faculty for this activity, has no relevant financial relationships.
Media: Internet
Computer System Requirements
This program requires the use of an internet-connected computer or device and a modern web browser capable of streaming video.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
